中国加入“新冠疫苗实施计划”

外交部发言人汪文斌2月3日表示，中国已正式加入“新冠疫苗实施计划”，并同世卫组织等发起方保持密切沟通，为把疫苗作为全球公共产品、实现发展中国家的可及性和可负担性而共同努力。

 

At the request of the World Health Organization (WHO), China has decided¹ to provide 10 million doses of COVID-19 vaccines² to COVAX, mainly to meet the urgent need in developing countries. This is another important measure taken by China to promote equitable³ distribution of vaccines, advance international cooperation in fighting the pandemic, and apply the vision of a community of common health for all.

应世卫组织方面请求，中方决定向“新冠肺炎疫苗实施计划”提供1000万剂疫苗，主要用于发展中国家急需。这是中方促进疫苗公平分配，推进国际抗疫合作，践行人类卫生健康共同体理念的又一重要举措。

 

汪文斌表示：

 

The WHO has started to review emergency use authorization⁴ for Chinese vaccines. The Chinese companies involved will continue to offer their close coordination⁵. We hope that the WHO will finish the review process as soon as possible.

世卫组织已开始审核中国疫苗的紧急使用授权。中国企业将继续积极配合。希望世卫组织尽早完成这项工作。

 

We hope that countries, with the capacity to do so, will take actions to actively⁶ support COVAX and the work of the WHO, help developing countries access vaccines in a timely manner, and make their due contributions to mankind's early victory over the pandemic.

我们希望国际社会有能力的国家都积极行动起来，以实际行动支持“实施计划”，支持世卫组织工作，帮助发展中国家及时获得疫苗，为国际社会早日战胜疫情作出应有的贡献。

分享到：